{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:53:38Z","timestamp":1780970018894,"version":"3.54.1"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>\n                    We report a case of a 64-year-old woman with Takayasu arteritis who underwent chemokine receptor CXCR4-targeted whole-body\n                    <jats:sup>68<\/jats:sup>\n                    Ga-Pentixafor positron emission tomography\/computed tomography (PET\/CT) for further evaluation of disease activity and exclusion of concurrent inflammatory diseases.\n                    <jats:sup>68<\/jats:sup>\n                    Ga-Pentixafor PET demonstrated CXCR4-positive inflammatory cell infiltrates in the aortic wall, and active disease was further confirmed by\n                    <jats:sup>18<\/jats:sup>\n                    F-fluorodeoxyglucose (FDG) PET\/CT. Moreover,\n                    <jats:sup>68<\/jats:sup>\n                    Ga-Pentixafor identified a CXCR4-positive pelvic bone lesion, and the patient was subsequently diagnosed with diffuse large B-cell lymphoma. CXCR4-targeted\n                    <jats:sup>68<\/jats:sup>\n                    Ga-Pentixafor PET is useful for the detection of active inflammation in Takayasu arteritis, and to detect neoplastic disease in this cohort with increased risk of malignancy.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000005975","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T17:09:44Z","timestamp":1747242584000},"page":"e70-e71","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["CXCR4-Targeted Imaging in Takayasu Arteritis Using 68Ga-Pentixafor PET\/CT"],"prefix":"10.1097","volume":"51","author":[{"given":"Thorsten","family":"Derlin","sequence":"first","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Witte","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology, Hannover Medical School, Hanover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"R1-20251210","first-page":"00307","article-title":"Takayasu arteritis: a geographically distant but immunologically proximal MHC-I-opathy","volume":"S2665-9913","author":"Abacar","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"R2-20251210","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1136\/ard-2022-223482","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for Takayasu arteritis","volume":"81","author":"Grayson","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"R3-20251210","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jcmg.2012.01.013","article-title":"Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences","volume":"5","author":"Tezuka","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"R4-20251210","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1097\/RLU.0000000000005426","article-title":"CXCR4-targeted PET imaging in hematologic malignancies: a systematic review and meta-analysis","volume":"50","author":"Chavoshi","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R5-20251210","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/RLU.0000000000004974","article-title":"C-X-C motif chemokine receptor 4-targeted radioligand therapy in hematological malignancies-myeloablative effects, antilymphoma activity, and safety profile","volume":"49","author":"Dreher","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R6-20251210","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1007\/s12350-019-01929-z","article-title":"Dissecting the target leukocyte subpopulations of clinically relevant inflammation radiopharmaceuticals","volume":"28","author":"Borchert","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"R7-20251210","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1097\/RLU.0000000000005073","article-title":"68Ga-Pentixafor PET\/CT for in vivo imaging of CXCR4 receptors in glioma demonstrating a potential for response assessment to radiochemotherapy: preliminary results","volume":"49","author":"Waheed","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R8-20251210","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2967\/jnumed.117.193037","article-title":"Integrating MRI and chemokine receptor CXCR4-targeted PET for detection of leukocyte infiltration in complicated urinary tract infections after kidney transplantation","volume":"58","author":"Derlin","year":"2017","journal-title":"J Nucl Med"},{"key":"R9-20251210","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/RLU.0000000000005374","article-title":"CXCR4-targeted 68Ga-Pentixafor PET\/CT imaging in inflammatory bowel disease","volume":"49","author":"Chen","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R10-20251210","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1007\/s00259-018-4076-2","article-title":"Imaging of chemokine receptor CXCR4 expression in culprit and nonculprit coronary atherosclerotic plaque using motion-corrected [68Ga]pentixafor PET\/CT","volume":"45","author":"Derlin","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R11-20251210","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keae503","article-title":"Chemokine receptor CXCR4 based positron emission tomography imaging in systemic sclerosis-related interstitial lung disease","author":"Kopp","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"R12-20251210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13550-025-01203-z","article-title":"CXCR4-targeted PET imaging in rheumatoid arthritis: a novel approach for monitoring disease activity and therapeutic response","volume":"15","author":"Han","year":"2025","journal-title":"EJNMMI Res"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:01:31Z","timestamp":1765371691000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005975","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"2025-02-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}